Plant Sterols
Dietary SupplementPlant sterols
NCT Number: NCT02288585
Double-blind, randomised, placebo-controlled, parallel group study with two intervention arms. The study will be conducted in 150 subjects and the primary objective is to show a fasting LDL-cholesterol and triglyceride lowering effect of plant sterols in subjects with established type 2 diabetes mellitus and subjects at high risk of developing type 2 diabetes.
Looking for future studies?
Notify Me30 year–75 year
All sexes
Interventional
Not applicable
CSIRO, Adelaide, Australia
The main aim of the study is to investigate the effect of plant sterols on fasting triglycerides and LDL-cholesterol concentrations.
This study also aims to study the effect of plant sterols on fasting total cholesterol, HDL-cholesterol concentrations and Lipoprotein (a). Furthermore the effects of plant sterols on fasting blood glucose and insulin will be explored. At last, in a sub-group, at end of intervention the acute, chronic and acute upon chronic effect of plant sterols on postprandial blood lipids, glucose and insulin responses during a mixed meal challenge rich in fat and carbohydrates will be explored.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Plant sterols
Placebo product
Time frame: At baseline (after 2 weeks run-in period) and after 6 weeks intervention
Time frame: At baseline (after 2 weeks run-in period) and after 6 weeks intervention
Time frame: At baseline (after 2 weeks run-in period) and after 6 weeks intervention
Time frame: At baseline (after 2 weeks run-in period) and after 6 weeks intervention
Time frame: At baseline (after 2 weeks run-in period) and after 6 weeks intervention
Time frame: At the end of intervention (after 6 weeks)
In a sub-group (n=48) of the population
Time frame: At baseline (after 2 weeks run-in period) and after 6 weeks intervention
Unilever R&D
Industry
The Effect of a Low-fat Spread Enriched With Plant Sterol Esters on the Blood Lipid Profile of Subjects With Established Type 2 Diabetes Mellitus and Subjects at High Risk of Developing Type 2 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02728583
Cardiovascular Diseases, Dyslipidemias
Berlin, Germany
View Trial DetailsNCT00000539
Arterial Occlusive Diseases, Cardiovascular Diseases
View Trial DetailsNCT01803178
Cardiovascular Diseases, Dyslipidemias
Berlin, Germany
View Trial DetailsNCT05198674
Cardiovascular Diseases, Chronic Disease
Birmingham, Alabama, United States
View Trial Details